H.-H. Capelle

Suggest Changes
Learn More
Objective. To study the effects of clazosentan, a new selective endothelin receptor subtype A antagonist, on cerebral perfusion and cerebral oxygenation following severe aneurysmal subarachnoid(More)
  • 1